7-methyl-2H-indazol-5-amine, 95%, 250mg

1-(3-Chlorophenyl)cyclopropanecarboxylic acid, 97.0%, 10g

4-Bromo-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 5g

GC-Kapillarsäule ROTI®Cap-5, unpolar, L 60 m, Ø-Innen 0,25 mm, Filmd. 0,50 µm, 1 Stück

3'-Bromophenyl acetylene, 97.0%, 25g

tert-Butyl (2S,3R)-3-hydroxy-2-methylazetidine-1-carboxylate, 97%, 10g

2-(2-Chlorophenyl)-5,7-dihydroxy-8-((3S,4R)-3-hydroxy-1-methylpiperidin-4-yl)-4H-chromen-4-one hydrochloride, 98%, 5mg

1-(3-Bromo-5-fluorophenyl)piperazine hydrochloride, 10g

1,3-Diiminoisoindoline>98.0%(T)25g

1-(2-(DIMETHYLAMINO)ETHYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID, 95%, 250mg

Ethyl 2-(imidazo[1,2-a]pyridin-3-yl)acetate, 95.0%, 1g

4-Chloro-2,5-difluorobenzamide, 98%, 2g

1,7-dimethyl-1H-indole-2-carboxylic acid, 95.0%, 100mg